Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.


Journal

Nutrition and cancer
ISSN: 1532-7914
Titre abrégé: Nutr Cancer
Pays: United States
ID NLM: 7905040

Informations de publication

Date de publication:
2023
Historique:
pmc-release: 01 01 2024
pubmed: 8 11 2022
medline: 25 2 2023
entrez: 7 11 2022
Statut: ppublish

Résumé

Modifiable lifestyle factors, such as following a healthy dietary pattern may delay or prevent prostate cancer (PCa) progression. However, few studies have evaluated whether following specific dietary patterns after PCa diagnosis impacts risk of disease progression among men with localized PCa managed by active surveillance (AS). 564 men enrolled in the Canary Prostate Active Surveillance Study, a protocol-driven AS study utilizing a pre-specified prostate-specific antigen monitoring and surveillance biopsy regimen, completed a food frequency questionnaire (FFQ) at enrollment and had ≥ 1 surveillance biopsy during follow-up. FFQs were used to evaluate adherence to the Dietary Guidelines for Americans (Healthy Eating index (HEI))-2015, alternative Mediterranean Diet (aMED), and Dietary Approaches to Stop Hypertension (DASH) dietary patterns. Multivariable-adjusted hazards ratios (HRs) and 95% confidence intervals were estimated using Cox proportional hazards models. During a median follow-up of 7.8 years, 237 men experienced an increase in Gleason score on subsequent biopsy (grade reclassification). Higher HEI-2015, aMED or DASH diet scores after diagnosis were not associated with significant reductions in the risk of grade reclassification during AS. However, these dietary patterns have well-established protective effects on chronic diseases and mortality and remain a prudent choice for men with prostate cancer managed by AS.

Identifiants

pubmed: 36343223
doi: 10.1080/01635581.2022.2143537
pmc: PMC9974882
mid: NIHMS1862320
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

618-626

Subventions

Organisme : NCI NIH HHS
ID : U01 CA224255
Pays : United States

Références

Curr Treat Options Oncol. 2007 Jun;8(3):173-96
pubmed: 17763836
Eur J Nutr. 2021 Apr;60(3):1561-1586
pubmed: 32770356
Cancer. 2021 Mar 1;127(5):720-728
pubmed: 33411364
N Engl J Med. 2016 Oct 13;375(15):1415-1424
pubmed: 27626136
Br J Nutr. 2011 Nov;106(10):1581-91
pubmed: 21736834
Am J Clin Nutr. 1995 Jun;61(6 Suppl):1402S-1406S
pubmed: 7754995
Am J Clin Nutr. 2003 Sep;78(3 Suppl):508S-513S
pubmed: 12936941
JAMA. 2019 Feb 19;321(7):704-706
pubmed: 30743264
Am J Epidemiol. 2008 May 15;167(10):1247-59
pubmed: 18344516
JAMA Netw Open. 2020 Dec 1;3(12):e2031349
pubmed: 33369661
Eur Urol. 2021 Mar;79(3):405-412
pubmed: 33422354
Ann Epidemiol. 1999 Apr;9(3):178-87
pubmed: 10192650
Cancer Prev Res (Phila). 2015 Jun;8(6):545-51
pubmed: 26031631
Arch Intern Med. 2008 Apr 14;168(7):713-20
pubmed: 18413553
J Acad Nutr Diet. 2015 May;115(5):780-800.e5
pubmed: 25680825
Curr Oncol Rep. 2021 Mar 10;23(3):37
pubmed: 33689041
J Nutr. 2014 Jun;144(6):881-9
pubmed: 24572039
Am J Clin Nutr. 2016 Jan;103(1):153-60
pubmed: 26561618
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
J Acad Nutr Diet. 2018 Sep;118(9):1591-1602
pubmed: 30146071
BJU Int. 2016 Mar;117(3):507-14
pubmed: 25604807
J Nutr. 2020 Feb 1;150(2):312-321
pubmed: 31529069
JAMA Surg. 2017 Oct 1;152(10):978-980
pubmed: 28636713
Nutr J. 2020 Apr 22;19(1):37
pubmed: 32321528
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
J Urol. 2016 Feb;195(2):313-20
pubmed: 26327354
Curr Opin Lipidol. 2002 Feb;13(1):3-9
pubmed: 11790957
Eur Urol. 2014 May;65(5):887-94
pubmed: 23962747
N Engl J Med. 1997 Apr 17;336(16):1117-24
pubmed: 9099655
Br J Cancer. 2019 Feb;120(4):466-471
pubmed: 30679782
JAMA. 2020 Jan 14;323(2):140-148
pubmed: 31935026
JAMA. 2015 Jul 7;314(1):80-2
pubmed: 26151271
Circulation. 2009 Mar 3;119(8):1093-100
pubmed: 19221219
J Am Diet Assoc. 1988 Oct;88(10):1268-71
pubmed: 3171020
Nutrients. 2020 Jun 27;12(7):
pubmed: 32605059
Ann Intern Med. 2018 Jan 2;168(1):1-9
pubmed: 29181514

Auteurs

Jeannette M Schenk (JM)

Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Menghan Liu (M)

Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Marian L Neuhouser (ML)

Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Lisa F Newcomb (LF)

Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Department of Urology, University of Washington, Seattle, Washington, USA.

Yingye Zheng (Y)

Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Kehao Zhu (K)

Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

James D Brooks (JD)

Department of Urology, Stanford University, Stanford, California, USA.

Peter R Carroll (PR)

Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.

Atreya Dash (A)

Veterans Affairs, Puget Sound, Seattle, Washington, USA.

William J Ellis (WJ)

Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Christopher P Filson (CP)

Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
Winship Cancer Institute, Emory Healthcare, Atlanta, Georgia, USA.

Martin E Gleave (ME)

Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, USA.

Michael Liss (M)

University of Texas Health Sciences Center, San Antonio, Texas, USA.

Frances M Martin (FM)

Department of Urology, Eastern Virginia Medical School, Virginia Beach, Virginia, USA.

Todd M Morgan (TM)

Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.

Andrew A Wagner (AA)

Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Daniel W Lin (DW)

Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Department of Urology, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH